Reparative properties of a commercial fish protein hydrolysate preparation by Fitzgerald, AJ et al.
Reparative properties of a commercial fish protein hydrolysate preparation
Fitzgerald, AJ; Rai, PS; Marchbank, T; Taylor, GW; Ghosh, S; Ritz, BW; Playford, RJ
 
 
 
 
 
 
 
For additional information about this publication click this link.
https://qmro.qmul.ac.uk/jspui/handle/123456789/157
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
doi:10.1136/gut.2004.060608 
 2005;54;775-781 Gut
  
Playford 
A J Fitzgerald, P S Rai, T Marchbank, G W Taylor, S Ghosh, B W Ritz and R J
  
 hydrolysate preparation
Reparative properties of a commercial fish protein
 http://gut.bmj.com/cgi/content/full/54/6/775
Updated information and services can be found at: 
 These include:
Data supplement
 http://gut.bmj.com/cgi/content/full/54/6/775/DC1
 "Competing interest statement"
 References
  
 http://gut.bmj.com/cgi/content/full/54/6/775#BIBL
This article cites 13 articles, 4 of which can be accessed free at: 
 service
Email alerting
top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at the
Topic collections
 (1280 articles) Nutrition and Metabolism 
 (373 articles) Culture 
 (538 articles) Basic sciences 
 (490 articles) Small intestine 
 (1016 articles) Histopathology 
  
Articles on similar topics can be found in the following collections 
 Notes   
 http://journals.bmj.com/cgi/reprintform
To order reprints of this article go to: 
 http://journals.bmj.com/subscriptions/
 go to: GutTo subscribe to 
 on 31 October 2007 gut.bmj.comDownloaded from 
EPITHELIAL CELL BIOLOGY
Reparative properties of a commercial fish protein
hydrolysate preparation
A J Fitzgerald, P S Rai, T Marchbank, G W Taylor, S Ghosh, B W Ritz, R J Playford
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
Professor R J Playford,
Department of
Gastroenterology, Imperial
College Faculty of
Medicine, Hammersmith
Hospital, Ducane Rd,
London W12 0NN, UK;
r.playford@
imperial.ac.uk
Revised version received
5 January 2005
Accepted for publication
10 January 2005
. . . . . . . . . . . . . . . . . . . . . . .
Gut 2005;54:775–781. doi: 10.1136/gut.2004.060608
Background: A partially hydrolysed and dried product of pacific whiting fish is currently marketed as a
health food supplement to support ‘‘intestinal health’’. However, there has been only limited scientific study
regarding its true biological activity.
Aims: We therefore tested its efficacy in a variety of models of epithelial injury and repair.
Methods: Effects on proliferation were determined using [3H] thymidine incorporation into epithelial rat
intestinal RIE-1 and human colonic HT29 cells. Effects on restitution (cell migration) were analysed using
wounded HT29 monolayers and its ability to influence gastric injury analysed using a rat indomethacin
restraint model. Partial characterisation of bioactive agents was performed using mass spectroscopy, high
pressure liquid chromatography, and gas chromatography.
Results: Both cell proliferation and cell migration were increased by about threefold when added at
1 mg/ml (p,0.01). Gastric injury was reduced by 59% when gavaged at 25 mg/ml (p,0.05), results
similar to using the potent cytoprotective agent epidermal growth factor at 12.5 mg/ml. The vast majority
of biological activity was soluble in ethanol, with glutamine in its single, di-, and tripeptide forms probably
accounting for approximately 40% of the total bioactivity seen. Fatty acid constituents may also have
contributed to cell migratory activity.
Conclusions: Fish protein hydrolysate possesses biological activity when analysed in a variety of models of
injury and repair and could provide a novel inexpensive approach for the prevention and treatment of the
injurious effects of non-steroidal anti-inflammatory drugs and other ulcerative conditions of the bowel.
Further studies appear justified.
N
atural medicinal products have been used for millen-
nia for the treatment of multiple ailments. Although
many have been superseded by conventional pharma-
ceutical approaches, there is currently a resurgence of interest
in the use of natural bioactive products by the general public,
with many healthy subjects and patients taking them for the
prevention and treatment of multiple conditions, including
gastrointestinal disorders.1 Unfortunately, current evidence
of the scientific validity of many of these traditional and
commercial compounds is severely limited.
Fermentation is a commonly used process in the standard
food industry as well as in the bioactive food (nutriceutical)
field. Fermented food products include those derived from
milk (yogurt, cheese, kefir), soy (natto, miso), fruits (wine),
vegetables (sauerkraut), and fish and meats. All have been
consumed for centuries for their nutritional or medicinal
properties.2 Fermentation of fish and meat was introduced as
a means of preservation, and fish sauces and pastes are
staples or condiments in Southeast Asian, Scandinavian, and
Eskimo cultures. Fermentation of food products has many
effects, including partial degradation of protein constituents
which, as well as aiding absorption from the gut, may also
influence its biological activity.
In the current study, we examined the potential bioactivity
of a fermented fish product, commercially available, that is
derived from the controlled proteolytic yeast fermentation of
pacific whiting (Merluccius productus) and which is claimed to
be beneficial for a variety of gut conditions. Although this
product is claimed to influence intestinal integrity, the data
on which it is based are severely limited, qualitative, and not
properly controlled. We have therefore performed a series of
studies to analyse this product for potential biological activity
with regard to mechanisms of gut integrity and repair using
well validated in vitro and in vivo models.
MATERIALS AND METHODS
All chemicals were purchased from Sigma (Poole, Dorset,
UK) unless otherwise stated.
Ethics
All animal experiments were approved by the Imperial
College School of Medicine Animals Ethics Committee and
covered by the appropriate licences under the Home Office
Animals Procedures Acts, 1986.
Hydrolysed fish protein concentrate
The dried fish protein hydrolysate preparation studied,
Seacure, was donated by Proper Nutrition, Inc. (Reading,
Pennsylvania, USA). The raw material for this product,
pacific whiting or hake (Merluccius productus), is obtained off
the coast of the Pacific Northwest of the USA and British
Columbia, Canada. The fish are cleaned, filleted, and minced.
The 18–24 hour fermentation process requires 10% ferment-
able carbohydrate (as sucrose) by weight in relation to fish
mince, 20% demineralised water, and 0.2% proprietary
proteolytic Hansenula yeast culture. Following fermentation,
0.2% oleoresin of rosemary (Kalsec, Kalamazoo, Indiana,
USA) is added as an antioxidant to stabilise lipids. The
ferment is then pasteurised at 80 C˚ for 20 minutes and finally
spray dried to a fine powder.
The fish protein hydrolysate contains 75–80% protein
constituents (60% peptides and 40% amino acids; data
obtained from Tektagen, King of Prussia, Pennsylvania,
USA). The major amino acid constituents of this
product are glutamine (approximately 14–16% of total),
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; EGF,
epidermal growth factor; HPLC, high pressure liquid chromatography;
PBS, phosphate buffer solution; BSA, bovine serum albumin
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asparagine (10%), and lysine (10%) (data obtained
from Eurofins, Memphis, Tennesse, USA). The combined
contribution of branched chain amino acids (lysine, leucine,
and isoleucine) comprise 23% of the total amino acid
content. This product also contains approximately 6–10%
fish oils which comprise approximately 20% saturated
fatty acids (primarily 16:0), 40% monounsaturates (16:1
n-7 and 18:1 n-9), and 40% polyunsaturates (20:5 n-3 and
22:6 n-3), and low levels of phospholipids (data obtained
from National Marine Fisheries Service, Charleston, South
Carolina, USA).
Study series A: effect of the fish protein hydrolysate
on in vitro models of repair
Background to methods
One of the earliest biological repair responses following injury
to tissue cells is migration of surviving cells over the denuded
area caused by the injury to re-establish epithelial integrity.
As it is extremely difficult to study this effect on organ tissue
inside a human or animal, cell culture models are commonly
used as surrogate markers of this promigratory response.
About 24 hours after the injury has occurred, there is also an
increase in the rate of cell division in order to re-establish a
normal mucosa. Cell culture models have traditionally been
also used as surrogate markers for this proliferation response,
and because thymidine is a natural constituent of DNA, [3H]
thymidine incorporation is commonly used as a marker of
proliferation. Cells that are actively dividing will therefore
increase their uptake of thymidine in the preparatory state of
cell division.
Cell migration as a model of wound repair
Cell migration assays were performed using our previously
published methods.3 Briefly, HT29 cells were grown to
confluence in six well plates in medium consisting of
Dulbecco’s modified Eagle’s medium (DMEM) containing
10% fetal calf serum at 37 C˚ in 5% CO2 and were then serum
starved for 24 hours. Monolayers were then wounded by
scraping a disposable pipette tip across the dishes, washed
with fresh serum free medium, and cultured in serum free
medium in the presence of fish hydrolysate or BSA (control
solution to examine non-specific protein effects) at various
concentrations up to 1.0 mg/ml. Additional monolayers
containing fish hydrosylate at 1 mg/ml also had the
proliferation inhibitor, mitomycin C, added at 0.5 mg/ml in
order to examine whether wound closure was dependant on
cell proliferation. The rate of movement of the anterior edges
of the wounded monolayers was then determined by taking
serial photomicrographs at various times after wounding.3 An
inverted microscope (Nikon TS100) and a Nikon Coolpix 800
digital camera with 125-fold magnification were used to
obtain photomicrographs. Identical regions were examined at
each time point by pre-marking the base of the plates to
facilitate alignment. Twenty measurements per field were
performed by placing a transparent grid over the photograph
and measuring the distance moved from the original wound
line. All results are expressed as the mean (SEM) of three
separate experiments.
Cell proliferation
Cell proliferation assays were performed using our previously
published methods.4 Briefly, rat intestinal epithelial (RIE-1)
cells and human colonic carcinoma (HT29) cells were
grown in DMEM containing glutamine and 10% fetal calf
serum. Effects of fish hydrolysate and epidermal growth
factor (EGF, positive control) were subsequently tested
under serum starved conditions. To assess the rate of cells
entering DNA synthesis, [3H] thymidine (2 mCi/well) was
included 24 hours after addition of the test factors and
cells were left for a further 24 hours. For each condition,
the stimulatory or inhibitory effects of the solutions
were measured in quadruplet in six separate wells. Cell
viability, determined by the ability to exclude 0.2% trypan
blue, was greater than 90% in both RIE-1 and HT29 cell
lines.
Study series B: stability of the bioactivity of the fish
protein hydrolysate in acid/pepsin in vitro
Background to method
Although products may be shown to possess biological
activity against cells in vitro, it is important to remember
that once ingested, they come into contact with the harsh
environment of the stomach acid and proteolytic enzymes
which can result in partial or complete abolition of activity. In
order to examine this possibility, the bioactive factor was
preincubated in conditions mimicking those found in the
stomach prior to subsequent analysis in the cell migration
assay.
Method
A stock solution of fish protein hydrolysate was made at a
concentration of 10 mg/ml by dissolving in phosphate
buffer solution (PBS). Four aliquots of the fish protein
solution were randomised to be incubated in either PBS
(pH 5.3, the pH of dissolved fish powder) or 0.1 M HCl, each
containing pepsin at 5000 units/ml for one hour at 37 C˚. At
the end of the incubation period, all samples were neutralised
using 0.1 M NaOH, and all test factors underwent a 1:10
dilution in DMEM to a final concentration of 1.0 mg/ml.
These solutions were then used to assess the rate of cell
migration in the wounded monolayer assay system described
earlier.
Study series C: effect of the fish protein hydrolysate
on an in vivo rat gastric damaging model
Background to method
Although cell culture studies provide valuable information
regarding potential bioactivity, additional information
may also be gained by extending studies to the in vivo
situation. The ability of the fish protein hydrolysate to
prevent gastric damage in rats stressed by indomethacin and
restraint was therefore also assessed using a well validated
model.3 5
Method
Male Sprague Dawley rats (225–275 g; Harlan Olac Ltd, UK)
were housed in standard cages (four animals per cage) and
fed standard laboratory chow (Special Diet Services, Essex,
UK) and tap water ad libitum.
Rats were randomised to receive, by gastric gavage, one of
the following: 2 ml of saline alone (containing BSA 0.2 mg/
ml), or varying concentrations of fish hydrolysate in saline at
a concentration of 5 mg/ml or 25 mg/ml, or a protein
standard (BSA) also at a concentration of 25 mg/ml. An
additional group was given EGF (12.5 mg/ml) as a positive
control. As in previous studies using this model, all solutions
also contained 2% hydroxymethyl-propylcellulose to reduce
the rate of gastric emptying.
Thirty minutes after gavage, all rats received indomethacin
(20 mg/kg subcutaneously) and were placed in Bollman-type
restraint cages. Animals were killed three hours later and
their stomachs removed, the pH of the stomachs was
measured, and then the stomachs were inflated with 4 ml
of 10% formalin. The stomachs were randomly coded and
macroscopic and microscopic assessments of injury were
assessed in a blinded fashion. Macroscopic injury was
assessed using a dissecting microscope (610) with the aid
of a reference square grid and reported as the total area of
776 Fitzgerald, Rai, Marchbank, et al
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ulceration per stomach (mm2/stomach). The stomachs were
then embedded in wax and the depth of damage assessed
microscopically, as previously described.5 Briefly, microscopic
injury was graded with a score from 0 to 4 where 0=no
damage, 1=one small erosion (,0.5 mm), 2= two small or
one large erosion (.0.5 mm), 3= two or more large erosions,
and 4=any area of ulceration extending to the muscularis
mucosa.
Study series D: investigation into active constituents
within the fish protein hydrolysate
Background to method
The fish protein hydrolysate contains multiple constituents
which may contribute to any bioactivity seen. In order to
begin to examine which are the key factors, we examined
whether the biological activity was transferable into an
ethanol phase, and following this procedure further analysed
the active fraction using mass spectroscopy. In addition, as
the fish hydrolysate is relatively rich in the amino acid
glutamine, we analysed the effect of adding glutamine or a
control amino acid, in similar amounts to those found in the
fish hydrolysate, to the cell culture systems.
Ethanol extraction of fish protein hydrolysate and
cell migration assay
To begin to examine the identity of the bioactive ingredients,
the ability of its biological activity to be soluble in ethanol
was determined. Fish powder was dispersed in ice cold 100%
aqueous ethanol (solid to liquid ratio 1:10, g/ml) in a flat
bottomed flask, stirred on ice for three hours. The ethanol
extracts (soluble substances) and ethanol insoluble sub-
stances as residues were separated by decantation. Samples
were dried on a centrifugal evaporator and resuspended in
DMEM back to the original volume. These solutions were
then used to assess the rate of cell migration after fish
hydrolysate ethanol extraction in the wounded monolayer
assay system, as described above.
HPLC mass spectrometry
The ethanolic extract was examined for polar components
using high pressure liquid chromatography (HPLC)
positive ion mass spectrometry. A sample of the ethanolic
extract was chromatographed using a Jasco HPLC system on a
Hichrom rpb column (10 cm62 mm id). A 45 minute
linear gradient of acetonitrile:water:formic acid (10:90:0.01–
80:20:0.01) was applied, eluting at 0.3 ml/min. The solvent
flow was directed through a diode array UV absorbance
monitor (Jasco) and split 1:13 into the electrospray
ion source of a Micromass Quattro II triple quadrupole mass
spectrometer operated in the positive ion mode. Nitrogen
was used as the nebulising and drying gas. Source
temperature was set at 75 C˚ with a cone voltage of 20 V.
One second scans were acquired from m/z 150–1100
throughout the HPLC run.
Gas chromatography electron impact mass
spectrometry
The ethanolic extract was examined for lipophilic compo-
nents using gas chromatography electron impact mass
spectrometry. Briefly, a sample of the ethanol extract was
esterified with ethereal diazomethane (30 minutes) followed
by treatment with bistrimethylsilyl trifluoroacetamide
(18 hours, room temperature). Excess reagents were removed
under a stream of nitrogen. The derivatised sample was
dissolved in decane for analysis by capillary gas chromato-
graphy mass spectrometry using a VG Trio 1000. The sample
was chromatographed on a 25 m DB1701 column using
helium as carrier gas and a temperature gradient of 5 C˚/min
from 150˚to 300 C˚. The injector was operated in the splitless
mode and the temperature was set at 250 C˚. The gas
chromatography column was routed into the electron impact
ion source of the mass spectrometer. The source temperature
was set at 200 C˚ and electron energy at 70 eV. One second
scans were obtained between m/z 70–700.
Effect of glutamine on cell migration
Cell migration assays were performed as described earlier.
Wells contained DMEM alone (negative control), the fish
hydrolysate at a final concentration of 1 mg/ml (this dose
was chosen as it gave maximal response), glutamine at
143 mg/ml (1 mmol/l, providing a similar amount of total
glutamine as that found in the fish hydrolysate when used at
1 mg/ml), and glycine at an identical molarity.
Statistics
All values are expressed as mean (SEM). One or two way
ANOVA was used as appropriate. Where a significant effect
was seen (p,0.05), individual comparisons were performed
using t tests based on group means, residual and degrees of
freedom obtained from the ANOVA, a method equivalent to
repeated measures analyses.
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Figure 1 Proliferative responses of HT29 (A) and RIE-1 (B) cells after
incubating with various doses of the fish hydrolysate. Proliferation was
assessed using [3H] thymidine incorporation. Data are presented as
mean (SEM); *p,0.05, **p,0.01 versus values found in control wells
(incubated in Dulbecco’s modified Eagle medium (DMEM) medium
alone). In both cell lines, typical ‘‘bell-shaped’’ dose-responses were
seen. Additional cells, incubated with 10 mg/ml of epidermal growth
factor (EGF), were used as a positive control.
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RESULTS
Study series A: effect of the fish protein hydrolysate
on in vitro models of repair
Cell proliferation
Proliferation assays revealed a typical ‘‘bell-shaped’’ dose-
response curve (fig 1). Maximal activity of the fish protein
hydrolysate was seen when utilised at a final concentration of
1 mg/ml in HT29 cells (fig 1A) and 0.1 mg/ml in RIE-1 cells
(fig 1B).
Cell migration as a model of wound repair
Addition of the fish powder to HT29 cells resulted in a
significant (p,0.05) dose dependant increase in cell migra-
tion. Maximal stimulation was seen at 1.0 mg/ml protein
concentration (fig 2A). Higher doses did not enhance
migration further (data not shown). Cells which had been
incubated with the fish hydrosylate and proliferation
inhibitor, mitomycin C, showed a similar pro-migratory
activity to that seen in wells incubated with fish hydrosylate
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Figure 2 Effect of fish hydrolysate on the rate of cell migration using an
in vitro model of wound repair. HT29 cells were grown as a monolayer
and a standard wound inflicted at time zero. The distance moved by the
leading edge was then determined using serial photomicrographs.
When added at concentrations above 0.1 mg/ml, addition of the fish
powder resulted in a significant (p,0.05) dose dependant increase in
cell migration (A), with maximal stimulation being seen at 1.0 mg/ml
protein concentration. To analyse whether these effects were non-
specific, due to the presence of protein constituents, pro-migratory
activity of the fish hydrolysate (1 mg/ml) was compared against cells
incubated with a control protein, bovine serum albumin (BSA) at the
same concentration (B). As the fish hydrolysate is likely to be taken
orally, the effect of preincubating the product in acid and pepsin for one
hour at 37 C˚ on its ability to stimulate migration was determined. No
loss of activity was seen (C). Data are presented as mean (SEM).
**p,0.01, culture conditions caused a significantly greater increase in
the distance migrated for all time points after four hours compared with
cells grown in media alone.
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Figure 3 Effect of the fish protein hydrolysate on gastric injury. Rats
were gavaged with 2 ml of control solution (saline with 0.2 mg/ml
bovine serum albumin (BSA)), fish hydrolysate at 5 and 25 mg/ml, or
epidermal growth factor (EGF, positive control) at 12.5 mg/ml. A further
group were given 25 mg/ml of BSA to determine specific from non-
specific effects of the fish hydrolysate. Rats were subsequently injected
with indomethacin (20 mg/kg subcutaneously) and placed in restraint
cages. Three hours later, animals were killed and the degree of
macroscopic (A) and microscopic (B) injury determined. Data are
presented as mean (SEM) of n =7–12 per group. *p,0.05, **p,0.01
versus control animals not given the fish hydrolysate, EGF, or BSA.
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alone, confirming that the restitutive effects seen were not
dependant on cell proliferation (data not shown). To
distinguish specific effects of hydrolysed white fish from
non-specific effects of protein addition, the effect of adding
BSA was tested when added at the same concentration. As
can be seen (fig 2B), BSA only caused a minor pro-migratory
effect.
Study series B: stability of the bioactivity of the fish
protein hydrolysate in acid/pepsin in vitro
Preincubation with pepsin alone, HCl alone, or pepsin/HCl
(fig 2C) had no effect on the restitutive properties of the fish
hydrolysate powder.
Study series C: effect of the fish protein hydrolysate
on an in vivo rat gastric damaging model
Animals that received indomethacin and restraint and a
placebo gavage had a mean macroscopic gastric damage score
of 20 (3.5) mm2/stomach. Administration of the fish protein
hydrolysate caused a dose dependant reduction in the
amount of gastric injury (fig 3A). This equated to a 16%
reduction in those animals that had received 5 mg/ml of the
hydrolysate and a 59% reduction in animals that had received
25 mg/ml of the hydrolysate. Histological assessment using
the microscopic scoring system gave similar results to those
seen macroscopically (fig 3B). Administration of the fish
hydrolysate at 25 mg/ml gave a gastric protective effect which
was roughly similar to that seen in animals that had received
the potent cytoprotective agent EGF at 12.5 mg/ml (fig 3).
Gastric pH assessment showed that all of these effects were
independent of alteration in pH (all gastric pH values were in
the range 1–3). The reduction in gastric injury resulting from
administration of the fish hydrolysate appeared to be a
specific effect, as administration of an equivalent amount of
BSA was ineffective in reducing the amount of injury (fig 3).
Study series D: investigation into active constituents
within the fish protein hydrolysate
Effect of ethanol extraction of fish protein
hydrolysate on cell migration
The vast majority of the biological activity, as determined by
following pro-migratory effects, was soluble in ethanol. A
typical result is shown in fig 4. Results from several studies
showed that incubation of the fish hydrolysate in absolute
ethanol for three hours resulted in approximately 73% of the
activity transferring to the ethanol phase (data not shown).
HPLC mass spectrometry and gas chromatography
mass spectrometry
As stated earlier, the ethanolic extract was examined by both
HPLC positive ion mass spectrometry for the polar compo-
nents and gas chromatography electron impact mass spectro-
metry for lipophilic components.
Reverse phase HPLC mass spectrometry of an aqueous:
acetonitrile:formic acid (90:10:0.01) extract of the dried
ethanolic sample showed a very large peak which eluted
within the first 2–3 minutes (fig 5, upper graph). Detailed
analysis of this zone showed that these polar compounds had
masses consistent with single amino acids and di- and
tripeptides (fig 5A inset) with molecular weights of 166, 227,
249, 265, 288, 278, 311, and 313. A number of unidentified
higher mass components were also present and eluted after
this initial 2–3 minute peak (fig 5, upper graph).
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Figure 4 Investigation into active constituents within the fish protein
hydrolysate: solubility into ethanol. Fish powder was mixed with 100%
aqueous ethanol and soluble substances and ethanol insoluble
substances as residues were separated by decantation. Samples were
dried on a centrifugal evaporator and re-suspended in Dulbecco’s
modified Eagle medium (DMEM) back to the original volume. The ability
of this ethanol extract to stimulate cell migration was then compared
against the original fish protein hydrolysate (1 mg/ml). Data are
presented as mean (SEM).
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Figure 5 Investigation into active constituents within the fish protein
hydrolysate: gas chromatography electron impact mass spectrometry
and high pressure liquid chromatography (HPLC) positive ion mass
spectrometry. The fish hydrolysate underwent ethanol extraction and was
then subjected to HPLC positive ion mass spectrometry in order to
analyse polar components (upper graph). A large early peak was seen
and detailed analysis of this region (inset) showed it to contain multiple
molecules with molecular weights of between 166 and 313 Da, in
keeping with single amino acids and di and tripeptides. The ethanol
extract was also analysed using gas chromatography electron impact
mass spectrometry to determine lipophilic components (lower graph). As
expected, the product contained a mixture of saturated and unsaturated
fatty acids. Identified molecules included: (a) C14:0, myristic acid;
(b) C16:1; (c) C16:0, palmitic acid; (d) C18:1, oleic acid; and
(e) C18:0, stearic acid, as well as a number of unidentifiable molecules.
Peak (f) is the plasticiser monoethyl hexyl phthalate which is a
preparation artefact, but is useful for quality control.
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Gas chromatography mass spectrometry of an unsaponi-
fied sample showed the presence of numerous compounds:
the major species present included a series of fatty acids
(C14:0–C20:0), together with their unsaturated and mono-
hydroxylated derivatives (C18:0-OH, C20:0-OH) (fig 5, lower
graph). A number of compounds were not further
characterised.
Effect of glutamine on cell migration
To allow easy comparison of the relative pro-restitutive
effects of the different agents, fig 6 shows the absolute
amount of cell movement that had occurred eight hours
following induction of injury to the monolayers. Compared
with controls, addition of the fish hydrosylate (1 mg/ml)
caused an approximate doubling of the rate of movement.
Cells grown in the presence of an equivalent amount of
glutamine as that found in the fish hydrolysate (1 mmol/l)
showed that about 34% of the total pro-migratory effect could
be attributable to the glutamine added in isolation. However,
addition of an equimolar amount of glycine (control amino
acid, 1 mmol/l) did not increase the migration of the leading
edge above values found in the control.
DISCUSSION
We have shown that a commercially available fish hydro-
lysate preparation possesses both pro-migratory and pro-
proliferative activity and is also able to reduce the degree of
injury sustained in an in vivo rat gastric damaging model. We
also showed that some, but not all, of these effects may be
due to the relatively high concentrations of glutamine and
glutamine containing peptides present within this product.
For the in vitro studies, rat small intestinal (RIE-1) and
human colonic (HT29) cells were used to show that these
effects were not species specific and to examine effects on
cells from different regions of the bowel. Studies examining
the potential beneficial effect of the fish hydrolysate on
gastric injury were performed using indomethacin induced
injury in rats, as we have previously validated this model
for other bioactive agents such as bovine colostrum,4 and
non-steroidal anti-inflammatory drugs, such as indometha-
cin, continue to be a major cause of morbidity and mortality
in humans.6 Caution always has to be shown, however, in
extrapolating results obtained from in vitro cancer cell lines
and animal models to the human situation.
Mass spectroscopy provides a rapid sensitive method of
determining the molecular weight of test molecules. In
combination with HPLC, it is able to accurately determine the
molecular weight of multiple polar constituents within
complex samples such as the fish hydrolysate. We have
previously used this method to examine partial cleavage of
bioactive peptides, such as growth factors, within complex
mixtures.7 Gas chromatography electron impact mass spec-
trometry provides a similar role for non-polar compounds.
Although both of these methods provide highly accurate data
with regard to molecular weight of compounds within such
mixtures, it is important to note that they are not particularly
useful for quantitative measurements where other techniques
have to be used.
Hundreds, if not thousands, of products are currently
marketed as ‘‘health food supplements’’8; 72% of the
American population use one or more health supplement
products regularly and 57% considered that these therapies
reduced their need for drugs and other medical therapies.
This results in an annual turnover of approximately £1.4
billion ($2.4 billion) in the UK and £10 billion ($18 billion) in
the USA, with about an 8% annual growth.8 The sources of
these ‘‘natural’’ products are diverse and include bacteria (for
example, probiotics), plant (for example, prebiotics, herbal
remedies), animal (for example, colostrum), insect (for
example, honey), and marine (for example, sponges, snails)
origins. A fuller review is provided by Ghosh and Playford.1
Unfortunately, current evidence of the scientific validity of
most of these traditional and commercial compounds is
severely limited and the level of evidence used in support of
their claims often falling well below that acceptable in the
medical and scientific community.
The fish hydrolysate studied in this article is already
marketed in the USA as an ‘‘over the counter’’ health food
supplement and, as with many of these products, its major
marketing strategy is via patient validatory statements. There
have, however, been some limited scientific studies.
Englender reported that use of the fish protein hydrolysate,
at a dosage of 3 g/day for 60 days, reduced the symptoms of
occasional diarrhoea and constipation, and alleviated bloat-
ing.9 However, this study followed a self reporting ques-
tionnaire protocol and was not placebo controlled. Similarly,
Thomas et al reported in abstract form, the results of a double
blind placebo controlled study of the effect of taking a fish
hydrolysate preparation on gut permeability, as assessed by
lactulose/mannitol ratios, in a total of 15 patients with
inflammatory bowel disease. Although the study showed
some decrease in permeability in the fish hydrolysate treated
arm, the change failed to reach significance and was possibly
confounded by studying a mixture of Crohn’s disease and
ulcerative colitis patients with varying degrees of disease
activity.10 It was because of this scarcity of firm data that we
decided to investigate this product.
Our studies have shown bioactivity of this product in a
variety of gut integrity and repair models. Factors present
within the product influenced the early (restitution) and later
(proliferative) responses as well as decreasing injury, via acid
independent means, in the non-steroidal anti-inflammatory
drug induced gastric injury model. Biological activity was
retained following acid/pepsin incubation and was also
shown to be present when administered orally to rats. This
is important as, although biological activity of some food
products may be demonstrated in vitro, this does not equate
to activity once ingested. For example, many peptide growth
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Figure 6 Comparison of the effect of glutamine and glycine on the rate
of cell migration using an in vitro model of wound repair. To allow
comparison across the different incubation conditions, the amount of cell
movement eight hours after wounding is shown. Cells incubated with the
fish hydrosylate at 1 mg/ml had an approximate doubling in the rate of
movement compared with controls. Addition of glutamine, at a
concentration equivalent to that found in the fish hydrosylate, showed
that approximately 34% of this activity could be attributed to the
glutamine in isolation. Addition of a control amino acid (glycine), at the
same concentration as glutamine, did not stimulate cell movement above
baseline. **p,0.01 versus Dulbecco’s modified Eagle’s medium
(DMEM) control.
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factors present in food materials are susceptible to acid/
pepsin and pancreatic proteolytic digestion, and are therefore
likely to be degraded to inactive forms soon after ingestion.7
The molecules responsible for these effects have been
incompletely defined but do appear to be soluble in ethanol.
Analysis of the bioactivity of glutamine within the product
suggested this component played an important part although
other undefined factors were also important. Glutamine has
previously been shown to be trophic to several intestinal cell
lines when tested at similar concentrations to the current
study.11 In addition, the dipeptide alanyl-glutamine has also
been shown to be pro-proliferative in vitro when used at a
similar concentration.12 This dipeptide product is sometimes
used in preference to glutamine, particularly for use in
patients, as it is more stable during storage. This has
relevance to the current study where much of the glutamine
is likely to be present in the di- and tripeptide form. Although
several studies have claimed beneficial effects of glutamine
supplementation in animal or human situations involving
injury, repair and bacterial translocation, particularly relating
to the small and large intestine (for review see Ziegler and
colleagues13), not all studies have shown positive effects (for
example, Hulsewe and colleagues14) and its use in the clinical
setting remains controversial.
Much of the amino acid constituents of the fish protein
hydrolysate remain in the intact protein or partially cleaved
form and it is possible that these intact proteins have direct
bioactivity. In addition, partial digestion of naturally occur-
ring proteins can result in the production of additional
bioactive molecules. For example, the amidated beta-caso-
morphin morphiceptin Tyr-Pro-Phe-Pro-NH2 is an opioid
peptide derived from partial digestion of bovine milk beta-
casein and, once produced, may well influence gut function.15
As stated earlier, the fish hydrolysate contains about
6–10% fish oils. A previous study by Ruthig and Meckling-
Gill has shown that n-3 and n-6 fatty acids can stimulate cell
migration in rat intestinal IEC-6 monolayers at concentra-
tions (individual polyunsaturated fats tested at 30 mmol/l)
similar to those likely to be present in the fish hydrolysate.16
Although the pro-restitutive activity may be partially
explained by the presence of these fatty acids, they are
unlikely to be relevant to the pro-proliferative activity found
in the current study as Ruthig and Meckling-Gill also showed
that addition of these fatty acids actually reduced prolifera-
tion of IEC-6 cells.16
Indomethacin causes damage to the gastrointestinal tract
by several mechanisms, including reduction of mucosal
prostaglandin levels, reduction of mucosal blood flow,
stimulating neutrophil activation, and possibly also stimulat-
ing apoptosis.17 It is likely that many of these mechanisms
will be influenced by the numerous factors present in the
hydrolysed fish preparation. For example, in addition to
direct effects of bioactive peptides, glutamine constituents
may have contributed to antioxidant activity via stimulation
of glutathione production, and fatty acid constituents may
have influenced the production of prostaglandins.
In conclusion, our studies have shown that a fish
hydrolysate product, commercially available as an over the
counter ‘‘health food’’ supplement for licensing purposes,
possesses biological activity when assessed using several
models of gut integrity and repair. It was able to induce the
same biological repair promoting responses as the potent
‘‘drug’’ epidermal growth factor when tested in both the in
vitro and in vivo situations. Although the absolute amount of
fish hydrolysate required to induce these effects was about
103 higher than EGF, it is important to note that consumers
are taking several grams of the fish hydrolysate per day
(commercial suppliers recommend 1 g, three times per day).
Concentrations likely to be reached in human gastric juice
are, therefore, likely to be at least as high as those used in the
rat gastric damaging model (5–25 mg/ml). These results
further emphasise that the division between ‘‘food products’’
and ‘‘drugs’’, when considered in terms of biological activity
(and potential safety aspects), is far from clear and that this
product should be considered as a ‘‘nutriceutical’’ or
functional food. Further studies appear justified.
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